Last updated on August 2017

Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis


Brief description of study

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States. One hundred fifty (150) subjects diagnosed with gastroparesis, who satisfy the selection criteria for the study, will be randomized to one of two treatment groups, active or placebo.

Detailed Study Description

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States. One hundred fifty (150) subjects diagnosed with gastroparesis, who satisfy the selection criteria for the study, will be randomized to one of two treatment groups, active or placebo. The study is divided into two phases: the screening phase and the evaluation phase. The screening phase includes a screening visit to evaluate subjects' preliminary eligibility for the study. During the screening phase, subjects will collect diary data for at least 4 weeks. The evaluation phase includes 4 weeks of randomized double-blind treatment.

Clinical Study Identifier: NCT02970968

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Vanda Pharmaceuticals

Vanda Investigational Site
Dothan, AL United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Huntsville, AL United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Tucson, AZ United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Palo Alto, CA United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
San Francisco, CA United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Largo, FL United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Miami, FL United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Athens, GA United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Indianapolis, IN United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Louisville, KY United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Marrero, LA United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Boston, MA United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Wyoming, MI United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Minneapolis, MN United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Pascagoula, MS United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Saint Louis, MO United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Hanover, NH United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Great Neck, NY United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
New York, NY United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Raleigh, NC United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Salisbury, NC United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Mentor, OH United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Tulsa, OK United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Philadelphia, PA United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Chattanooga, TN United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
Nashville, TN United States
  Connect »

Vanda Pharmaceuticals

Vanda Investigational Site
El Paso, TX United States
  Connect »